Written out as a formula, CBD and THC are the same compound: twenty-one carbons, thirty hydrogens, two oxygens. The difference between them is architectural rather than compositional, and it is enough to make one molecule intoxicating and the other not.
Identical ingredients, different building
Chemists call molecules like these isomers: same atoms, same count, different arrangement. In THC, part of the structure folds back and closes into an additional ring. In CBD, that same region stays open, leaving two free hydroxyl groups exposed where THC has a closed loop.
It is a small edit on paper. In three dimensions it is not small at all. Molecular recognition in the body works on shape and on where charged or reactive groups sit on the surface of a molecule. Closing a ring changes the overall geometry, changes which parts of the molecule are free to interact, and changes how rigid the whole structure is. Two buildings made from the same pile of bricks can have doors in entirely different places.
How the plant produces both from one precursor
The plant does not make CBD and THC independently. It makes a single precursor compound and then commits it, via one enzyme or another, to becoming cannabidiolic acid or tetrahydrocannabinolic acid. Which enzyme a plant expresses is genetic, which is why cultivar selection determines the cannabinoid profile far more than growing technique does.
Canadian law leans on exactly this. Industrial hemp is defined by a low ceiling on THC content in the flowering heads and leaves, so "hemp" is a legal and agronomic category describing the chemistry a cultivar produces, not a separate species. Both acids convert to their familiar neutral forms when heated, which is why raw plant material and a heated extract are chemically different starting points.
Why shape decides what happens at the receptor
The body has cannabinoid receptors of its own, part of a signalling system that was there long before anyone cultivated the plant. CB1 receptors are densely represented in the brain and central nervous system. THC fits the main binding site on CB1 and activates it, and that activation is what produces intoxication.
CBD does not do this. Its affinity for that same binding site is very low, and it is generally described as acting on the receptor indirectly, altering how the receptor responds to other molecules rather than switching it on. Researchers have also proposed a list of other targets for CBD elsewhere in the body, including certain serotonin receptors, particular ion channels, and enzymes that handle the body's own cannabinoid-like compounds. Those mechanisms are actively studied and are not settled science, which is a reason to be sceptical of any confident, simple story about how CBD works.
Does CBD turn into THC in your stomach?
This question circulates because there is a genuine chemical basis for it. Under strong acid in a laboratory flask, CBD can be cyclized into THC. That reaction is well documented, and it is the origin of the claim.
The leap from a flask to a person is the problem. Laboratory conditions designed to force a reaction are not equivalent to the conditions in a human digestive tract, and studies attempting to demonstrate the effect in people have not supported meaningful conversion under normal use. Where CBD users show THC in their system, the far more ordinary explanation is that the product contained THC in the first place, either by design in a full-spectrum formulation or by inaccurate labelling.
Where the chemistry lands in real products
- Legal treatment. Canada regulates CBD as cannabis regardless of which plant it came from, so the isomer distinction does not create a legal shortcut.
- Testing. Drug tests target THC and its metabolites, not CBD. Confirmatory laboratory methods identify specific molecules and are not confused by structural similarity.
- Product design. Broad-spectrum and isolate products exist precisely because these two isomers can be separated after extraction, using chromatography and crystallization.
- Labelling. A certificate of analysis reports each cannabinoid separately, which is why the document is more informative than any phrase on the front of a box.
If you want the practical consequences rather than the chemistry, the product and buying guides in our article index cover spectrum types, lab reports and Canadian rules.
The useful takeaway
When someone tells you CBD and THC are "basically the same thing because they have the same formula", they have the chemistry right and the conclusion backwards. Formula describes inventory; structure describes function. The practical version is this: read the cannabinoid table on a certificate of analysis rather than the adjectives on the carton, note the THC figure specifically, and remember that a product's spectrum type is a claim about a separation step that either did or did not happen, and the lab report is where you find out which.
This is general information, not medical advice. Speak with a healthcare professional about your own situation before using any cannabis product.